Home / Pharmaceutical / Global Urinary Tract Infection (UTI) Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies And Forecasts, 2017 To 2025

Global Urinary Tract Infection (UTI) Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies And Forecasts, 2017 To 2025

Published: Oct 2017 | Published By: Acute Market Research

Urinary Tract Infection (UTI) Treatment Market - Growth, Future Prospects and Competitive Analysis, 2017 - 2025 the global urinary tract infection (UTI) treatment market was valued at US$ xx Bn in 2016, and is expected to reach US$ xx Bn by 2025, expanding at a CAGR of 3.2% from 2017 to 2025.

Market Insights:
Urinary tract infection (UTI) is a common infections of the urinary tract, which consists of the kidneys, ureters, bladder, urethra or prostate gland. For the purpose of the study UTI treatment market is segmented on the basis of drug type such as penicillin, quinolones, cephalosporin, sulphonamides, tetracycline and other. Among the considered drug type, demand for quinolones is highest in market as these are preferred as first line treatment option. Physician generally prescribe a quinolone medicine if there is no other treatment options existing for a treatment of complicated UTI or kidney infection. In the base year 2016, North America dominated the global UTI treatment market due to large number of target population, higher treatment awareness, swift adoption of novel medications, better reimbursement policies acting as the prime contributors to the dominance of North America. On the other hand, Asia Pacific will show highest UTI treatment market growth during forecast period due to increasing healthcare awareness among general population and growing partnership of key players with local manufacturer.

Market Competition Assessment:
The urinary tract infection (UTI) treatment market is observed to be highly competitive and comprises large number of players. However, some major market players are AstraZeneca plc., Bayer AG, Cubist Pharmaceuticals, F. Hoffmann–La Roche Ltd., GlaxoSmithKline Pharmaceuticals Ltd., Johnson & Johnson, MerLion Pharmaceuticals, Osel Inc., Pfizer Inc., Rempex Pharmaceuticals and other.

Key Market Movements:
• Factors such as increase in prevalence of UTI, higher treatment compliance, changing lifestyle pattern and favorable reimbursement policies in some countries are driving the growth of UTI treatment market worldwide.
• Rising access for the treatment medication in developing countries would fuel the growth of UTI treatment market during forecast period.
• However, generic erosion, poor patient compliance in some countries and adverse effects associated with the use of medication is negatively impacting the growth of UTI treatment market.

Chapter 1 Preface
1.1 Report Description
1.1.1 Purpose of the Report
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Scope
1.3 Research Methodology
1.3.1 Phase I – Secondary Research
1.3.2 Phase II – Primary Research
1.3.3 Phase III – Expert Panel Review
1.3.4 Assumptions

Chapter 2 Executive Summary
2.1 Global Urinary Tract Infection (UTI) Treatment Market Snapshot
2.2 Global Urinary Tract Infection (UTI) Treatment Market, by Drug Class
2.3 Global Urinary Tract Infection (UTI) Treatment Market Share, by Geography, 2016 (Value %)

Chapter 3 Urinary Tract Infection (UTI) Treatment Market Analysis
3.1 Global Urinary Tract Infection (UTI) Treatment Market Overview
3.2 Market Dynamics
3.2.1 Market Drivers
3.2.2 Challenges
3.2.3 Opportunities
3.3 Attractive Investment Proposition
3.4 Competitive Landscape of Key Players in Urinary Tract Infection (UTI) Treatment Market
3.5 Top 3 Countries

Chapter 4 Global Urinary Tract Infection (UTI) Treatment Market, by Drug Class
4.1 Overview
4.2 Attractive Investment Proposition: Global Urinary Tract Infection (UTI) Treatment Market, by Drug Class
4.3 Penicillin
4.4 Quinolones
4.5 Cephalosporin
4.6 Sulphonamides
4.7 Tetracycline
4.8 Other

Chapter 5 Global Urinary Tract Infection (UTI) Treatment Market, By Geography
5.1 Preface
5.2 North America (U.S. & Canada)
5.2.1 North America Urinary Tract Infection (UTI) Treatment Market, by Drug Class, 2015- 2025 (US$)
5.2.2 North America Urinary Tract Infection (UTI) Treatment Market, by Country, 2015- 2025 (US$)
5.3 Europe (U.K., Germany & Rest of Europe)
5.3.1 Europe Urinary Tract Infection (UTI) Treatment Market, by Drug Class, 2015- 2025 (US$)
5.3.2 Europe Urinary Tract Infection (UTI) Treatment Market, by Country, 2015- 2025 (US$)
5.4 Asia Pacific (China, Japan and Rest of APAC)
5.4.1 Asia Pacific Urinary Tract Infection (UTI) Treatment Market, by Drug Class, 2015- 2025 (US$)
5.4.1 Asia Pacific Urinary Tract Infection (UTI) Treatment Market, by Country, 2015- 2025 (US$)
5.5 Latin America (Brazil, Mexico and Rest of LATAM)
5.5.1 Latin America Urinary Tract Infection (UTI) Treatment Market, by Drug Class, 2015- 2025 (US$)
5.5.2 Latin America Urinary Tract Infection (UTI) Treatment Market, by Country, 2015- 2025 (US$)
5.6 Middle East and Africa (GCC and Rest of MEA)
5.6.1 Middle East and Africa Urinary Tract Infection (UTI) Treatment Market, by Drug Class, 2015- 2025 (US$)
5.6.2 Middle East and Africa Urinary Tract Infection (UTI) Treatment Market, by Country, 2015- 2025 (US$)

Chapter 6 Company Profiles
6.1 AstraZeneca plc.
6.2 Bayer AG
6.3 Cubist Pharmaceuticals
6.4 F. Hoffmann–La Roche Ltd.
6.5 GlaxoSmithKline Pharmaceuticals Ltd.
6.6 Johnson & Johnson
6.7 MerLion Pharmaceuticals
6.8 Osel Inc.
6.9 Pfizer Inc.
6.10 Rempex Pharmaceuticals

TABLE 1 Market Positioning of Key Players in Global Urinary Tract Infection (UTI) Treatment Market
TABLE 2 Top 3 Countries in Global Urinary Tract Infection (UTI) Treatment Market
TABLE 3 Global Urinary Tract Infection (UTI) Treatment Market, by Drug Class, 2015 – 2025 (US$ Bn)
TABLE 4 Global Urinary Tract Infection (UTI) Treatment Market, by Geography, 2015 – 2025 (US$ Bn)
TABLE 5 North America Urinary Tract Infection (UTI) Treatment Market, by Drug Class, 2015-2025 (US$ Bn)
TABLE 6 North America Urinary Tract Infection (UTI) Treatment Market, by Country, 2015 – 2025 (US$ Bn)
TABLE 7 Europe Urinary Tract Infection (UTI) Treatment Market, by Drug Class, 2015-2025 (US$ Bn)
TABLE 8 Europe Urinary Tract Infection (UTI) Treatment Market, by Country, 2015 – 2025 (US$ Bn)
TABLE 9 Asia Pacific Urinary Tract Infection (UTI) Treatment Market, by Drug Class, 2015-2025 (US$ Bn)
TABLE 10 Asia Pacific Urinary Tract Infection (UTI) Treatment Market, by Country, 2015 – 2025 (US$ Bn)
TABLE 11 Latin America Urinary Tract Infection (UTI) Treatment Market, by Drug Class, 2015-2025 (US$ Bn)
TABLE 12 Latin America Urinary Tract Infection (UTI) Treatment Market, by Country, 2015 – 2025 (US$ Bn)
TABLE 13 Middle East and Africa Urinary Tract Infection (UTI) Treatment Market, by Drug Class, 2015-2025 (US$ Bn)
TABLE 14 Middle East and Africa Urinary Tract Infection (UTI) Treatment Market, by Country, 2015 – 2025 (US$ Bn)
TABLE 15 AstraZeneca plc.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 16 Bayer AG: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 17 Cubist Pharmaceuticals: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 18 F. Hoffmann–La Roche Ltd.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 19 GlaxoSmithKline Pharmaceuticals Ltd.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 20 Johnson & Johnson: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 21 MerLion Pharmaceuticals: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 22 Osel Inc.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 23 Pfizer Inc.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 24 Rempex Pharmaceuticals: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)

FIG. 1 Urinary Tract Infection (UTI) Treatment Market: Research Methodology
FIG. 2 Global Urinary Tract Infection (UTI) Treatment Market, by Drug Class, 2016 (US$ Bn)
FIG. 3 Global Urinary Tract Infection (UTI) Treatment Market Share, by Geography, 2016 (Value %)
FIG. 4 Attractive Investment Proposition: Global Urinary Tract Infection (UTI) Treatment Market, by Geography, 2016
FIG. 5 Attractive Investment Proposition: Global Urinary Tract Infection (UTI) Treatment Market, by Drug Class, 2016
FIG. 6 Global Penicillin Market, 2015 – 2025 (US$ Bn)
FIG. 7 Global Quinolones Market, 2015 – 2025 (US$ Bn)
FIG. 8 Global Cephalosporin Market, 2015 – 2025 (US$ Bn)
FIG. 9 Global Sulphonamides Market, 2015 – 2025 (US$ Bn)
FIG. 10 Global Tetracycline Market, 2015 – 2025 (US$ Bn)
FIG. 11 Global Other Drugs in UTI treatment Market, 2015 – 2025 (US$ Bn)

Choose License Type
 
Contact Information
24/7 Research Support
Phone: +1-855-455-8662
sales@acutemarketreports.com
Get in Touch with us
join us on Facebook
Follow us on Twitter
Follow us on LinkedIn
Add us on Google +